Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) reported Q1 EPS of $0.11, $0.09 better than the analyst estimate of $0.02. Revenue for the quarter came in at $137.7 million versus the consensus estimate of $131.07 million.

For earnings history and earnings-related data on Kiniksa Pharmaceuticals, Ltd. (KNSA) click here.